Health and Wellness

Beyond the Scale: Rutgers Study Links GLP-1 Medications to Reductions in Violent Impulses

Popular GLP-1 receptor agonists—most notably Ozempic and Wegovy—have fundamentally reshaped the landscape of metabolic medicine. Initially approved for the management...